These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36823953)

  • 1. Intravenous iron in patients with heart failure and iron deficiency: an updated meta-analysis.
    Graham FJ; Pellicori P; Kalra PR; Ford I; Bruzzese D; Cleland JGF
    Eur J Heart Fail; 2023 Apr; 25(4):528-537. PubMed ID: 36823953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intravenous iron replacement on recurrent heart failure hospitalizations and cardiovascular mortality in patients with heart failure and iron deficiency: A Bayesian meta-analysis.
    Anker SD; Khan MS; Butler J; von Haehling S; Jankowska EA; Ponikowski P; Friede T
    Eur J Heart Fail; 2023 Jul; 25(7):1080-1090. PubMed ID: 37062867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous iron for heart failure with evidence of iron deficiency: a meta-analysis of randomised trials.
    Graham FJ; Pellicori P; Ford I; Petrie MC; Kalra PR; Cleland JGF
    Clin Res Cardiol; 2021 Aug; 110(8):1299-1307. PubMed ID: 33755777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Hemoglobin Levels and Efficacy of Intravenous Ferric Carboxymaltose in Patients With Acute Heart Failure and Iron Deficiency: An AFFIRM-AHF Subgroup Analysis.
    Filippatos G; Ponikowski P; Farmakis D; Anker SD; Butler J; Fabien V; Kirwan BA; Macdougall IC; Metra M; Rosano G; Ruschitzka F; van der Meer P; Wächter S; Jankowska EA;
    Circulation; 2023 May; 147(22):1640-1653. PubMed ID: 37051919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous iron therapy for heart failure and iron deficiency: An updated meta-analysis of randomized clinical trials.
    Ahmed M; Shafiq A; Javaid H; Singh P; Shahbaz H; Maniya MT; Jain H; Shakir N; Cheema HA; Ahmad A; Rehman WU; Yeap G; Nashwan AJ; Minhas AMK; Ahmed R; Fudim M; Fonarow GC
    ESC Heart Fail; 2024 Jul; ():. PubMed ID: 38965691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of intravenous iron therapy in patients with heart failure and iron deficiency: Meta-analysis and trial sequential analysis of randomized clinical trials.
    Bhatia K; Sabharwal B; Gupta K; Lopez PD; Kaur A; Bhatia HK; Gandhi KD; Niroula S; Correa A; Birati EY; Argulian E; Fox A; Mahmood K
    J Cardiol; 2024 Feb; 83(2):105-112. PubMed ID: 37380069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-Analysis and Metaregression of the Treatment Effect of Intravenous Iron in Iron-Deficient Heart Failure.
    Martens P; Augusto SN; Mullens W; Tang WHW
    JACC Heart Fail; 2024 Mar; 12(3):525-536. PubMed ID: 38069996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mineralocorticoid receptor antagonists with sodium-glucose co-transporter-2 inhibitors in heart failure: a meta-analysis.
    Banerjee M; Maisnam I; Pal R; Mukhopadhyay S
    Eur Heart J; 2023 Oct; 44(37):3686-3696. PubMed ID: 37605637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of intravenous iron repletion in patients with heart failure: a systematic review and meta-analysis.
    Vukadinović D; Abdin A; Emrich I; Schulze PC; von Haehling S; Böhm M
    Clin Res Cardiol; 2023 Jul; 112(7):954-966. PubMed ID: 37074386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous iron infusion in patients with heart failure: a systematic review and study-level meta-analysis.
    Salah HM; Savarese G; Rosano GMC; Ambrosy AP; Mentz RJ; Fudim M
    ESC Heart Fail; 2023 Apr; 10(2):1473-1480. PubMed ID: 36734033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial.
    McGuire DK; Van de Werf F; Armstrong PW; Standl E; Koglin J; Green JB; Bethel MA; Cornel JH; Lopes RD; Halvorsen S; Ambrosio G; Buse JB; Josse RG; Lachin JM; Pencina MJ; Garg J; Lokhnygina Y; Holman RR; Peterson ED;
    JAMA Cardiol; 2016 May; 1(2):126-35. PubMed ID: 27437883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of intravenous and oral iron supplements for the treatment of iron deficiency in patients with heart failure: A network meta-analysis of randomized controlled trials.
    Mei Z; Chen J; Luo S; Jin L; Liu Q; Chen Y
    Pharmacol Res; 2022 Aug; 182():106345. PubMed ID: 35810949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Intravenous Iron in Patients with Heart Failure with Reduced Ejection Fraction and Iron Deficiency: A Systematic Review and Meta-Analysis of Randomized Control Trials.
    Sephien A; Dayto DC; Reljic T; Prida X; Joly JM; Tavares M; Katz JN; Kumar A
    Am J Cardiovasc Drugs; 2024 Mar; 24(2):285-302. PubMed ID: 38519808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular Outcomes with SGLT-2 inhibitors in patients with heart failure with or without type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials.
    Singh AK; Singh R
    Diabetes Metab Syndr; 2021; 15(1):351-359. PubMed ID: 33503584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of iron deficiency on long-term clinical outcomes of hospitalized patients with heart failure.
    Nakano H; Nagai T; Sundaram V; Nakai M; Nishimura K; Honda Y; Honda S; Iwakami N; Sugano Y; Asaumi Y; Aiba T; Noguchi T; Kusano K; Yokoyama H; Ogawa H; Yasuda S; Chikamori T; Anzai T;
    Int J Cardiol; 2018 Jun; 261():114-118. PubMed ID: 29580659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis.
    Ponikowski P; Mentz RJ; Hernandez AF; Butler J; Khan MS; van Veldhuisen DJ; Roubert B; Blackman N; Friede T; Jankowska EA; Anker SD
    Eur Heart J; 2023 Dec; 44(48):5077-5091. PubMed ID: 37632415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Once-Weekly Exenatide in Patients With Type 2 Diabetes Mellitus With and Without Heart Failure and Heart Failure-Related Outcomes: Insights From the EXSCEL Trial.
    Fudim M; White J; Pagidipati NJ; Lokhnygina Y; Wainstein J; Murin J; Iqbal N; Öhman P; Lopes RD; Reicher B; Holman RR; Hernandez AF; Mentz RJ
    Circulation; 2019 Nov; 140(20):1613-1622. PubMed ID: 31542942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating Iron Deficiency (ID) Anemia in Heart Failure (HF) Patients with IV Iron: A Meta-Analysis.
    Ogugua FM; Aguilar FA; Gamam A; Maqsood MH; Yoo TK; Kasmi F; AlKowatli O; Lo K
    Cureus; 2023 Jul; 15(7):e41895. PubMed ID: 37581143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial.
    Kalra PR; Cleland JGF; Petrie MC; Thomson EA; Kalra PA; Squire IB; Ahmed FZ; Al-Mohammad A; Cowburn PJ; Foley PWX; Graham FJ; Japp AG; Lane RE; Lang NN; Ludman AJ; Macdougall IC; Pellicori P; Ray R; Robertson M; Seed A; Ford I;
    Lancet; 2022 Dec; 400(10369):2199-2209. PubMed ID: 36347265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.